Redeye increase our growth expectations for the long term while making minor adjustments for the near term. The optimistic outlook remains, with continued positive momentum both in the short and medium term. The Q2 report makes us even more confident in the long-term growth story and sees a positive trajectory for the company in the coming years. Due to increased long-term growth assumptions, we have increased our fair value range and base case value.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/